Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-856,753
Closed -$84.3M 76
2025
Q2
$84.3M Buy
856,753
+20,336
+2% +$1.92M 4.53% 5
2025
Q1
$77.5M Buy
836,417
+126,002
+18% +$11.6M 4.85% 5
2024
Q4
$64.5M Buy
+710,415
New +$65.2M 4.52% 6
2023
Q4
Sell
-8,450
Closed -$789K 50
2023
Q3
$789K Sell
8,450
-19,100
-69% -$1.76M 0.04% 40
2023
Q2
$2.52M Buy
+27,550
New +$2.26M 0.14% 37

Other funds holding AMED

TIG Advisors LLC's AMED Position: Q3 2025 in Review

TIG Advisors LLC sold out of Amedisys (AMED) in Q3 2025, closing a stake of 856,753 shares — an estimated $84.3M sold.

TIG Advisors LLC first reported a position in AMED in Q2 2023 and held it in 5 quarters. The position peaked at $84.3M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • TIG Advisors LLC reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • TIG Advisors LLC sold 856,753 Amedisys shares in Q3 2025, an estimated $84.3M.
  • TIG Advisors LLC first reported a position in Amedisys in Q2 2023 and held it in 5 quarters.
  • TIG Advisors LLC's Amedisys position peaked at $84.3M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on TIG Advisors LLC's 13F filing for Q3 2025, filed 14 Nov 2025.